Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 39

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 39
---
 stock units also vest over four years with 1/16th of the covered shares vesting on each quarterly anniversary of the grant date, subject to the respective grantee’s continued service through the applicable vesting date. In determining the appropriate target value for these equity awards, the Compensation Committee considered several factors, including the specific responsibilities and experience of each Named Executive Officer, his or her individual performance, Company performance, parity among our Named Executive Officers, and the

29

recommendations of our CEO (except with respect to his own equity award). The Compensation Committee-approved equity grants were as follows:

| Executive      |     | Option Awards |           |     | Restricted Stock Unit Awards |         |
| Craig Collard  |     |               | 1,324,502 |     |                              | 220,750 |
| Ira Duarte     |     |               |   371,935 |     |                              |  61,989 |
| William Forbes |     |               |   371,935 |     |                              |  61,989 |

Equity awards are discretionary. The Compensation Committee generally grants equity awards to Named Executive Officers during its regularly scheduled meeting early in the fiscal year. However, the timing of this approval may be changed in the event of extraordinary circumstances, including in connection with mid-year promotions and new-hires. Eligible employees, including our Named Executive Officers, may voluntarily enroll in our Amended and Restated 1997 Employee Stock Purchase Plan ("Employee Stock Purchase Plan") and receive an option to purchase shares at a discount using payroll deductions accumulated during the prior six-month period. Purchase dates under the Employee Stock Purchase Plan are generally the last trading day in April and October. The Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity awards in 2024. The Compensation Committee does not time the release of material nonpublic information to affect the value of executive compensation. Employee Benefit Program Our ESPP provides employees with an opportunity for increased equity ownership in the Company. Other than the health and welfare benefits generally available to all employees, Named Executive Officers do not receive any other special benefits or perquisites. Our retirement savings plan (“401(k) Plan”) is a tax-qualified retirement savings plan, pursuant to which all employees, including the Named Executive Officers, are able to contribute the lesser of one hundred percent (100%) of their annual compensation (as defined in the 401(k) Plan) or the limit prescribed by the Internal Revenue Service to the 401